Dr. Marcela Maus is the Director of Cellular Immunotherapy at the Massachusetts General Hospital Cancer Center, Professor of Medicine at Harvard Medical School, the Paula O’Keefe Chair in Oncology, and Associate Physician in the division of Hematology/Oncology at the Massachusetts General Hospital. Dr. Maus is also an Associate Member of the Broad Institute of Harvard and MIT, and an Associate Member of the Ragon Institute of MGH, MIT, and Harvard.
Dr. Maus is a translational physician-scientist in the field of immunology, particularly as it relates to cancer. Her research program spans basic mechanisms of human immunology to design and test novel immune-based therapeutic interventions in vitro, in mouse models, and in patients. Her group has initiated novel clinical trials of cell therapies in lymphoma, myeloma, glioblastoma, and has ongoing projects to enhance CAR T cells for multiple solid tumors.
Dr. Maus received her S.B. from the Massachusetts Institute of Technology, and her M.D. and Ph.D. degrees from the University of Pennsylvania. Dr. Maus trained in internal medicine at University of Pennsylvania and in hematology and medical oncology at Memorial Sloan Kettering.